BGPT: Author Review: Zeping Han

Explore by Goal

Quick Explanation Copied

Zeping Han — scientific profile snapshot

Based only on the bibliometrics and paper titles provided, the work appears concentrated in translational/biomarker and cancer microenvironment/omics themes, with some epidemiologic genetics (e.g., Mendelian randomization) elements.

Cited metrics: OpenAlex reports works_count=65, cited_by_count=1422, h_index=19 for the “Zeping Han” match used here.

Note: h-index interpretation depends on field norms and author name disambiguation. (h-index concept: )

Long Explanation

Author Review: Zeping Han

Scope of evidence used: Only (i) the bibliometrics values and (ii) the list of paper titles you provided, plus the general definition of h-index.

Scientific stance: I avoid inferring methods, patient cohorts, effect sizes, or mechanisms beyond what is explicitly present in the provided titles/metrics.

1) Citation metrics (quality signals, but not proof)

OpenAlex match (as supplied): works_count=65, cited_by_count=1422, h_index=19. For h-index interpretation, see Hirsch’s definition.

Skeptical checks: h-index can be inflated by name disambiguation errors and varies widely by field and publication age; citations are a proxy for attention, not guaranteed causal contribution.

2) Paper-topic map (from titles only)

Your provided paper list includes multiple strands. Without abstracts/methods, I classify only at the level suggested by each title.

Important limitation: This is not a performance/impact metric; it is only a coarse topical categorization derived from titles you provided.

3) Strengths suggested by the evidence provided

Cross-domain applied biology. Titles span cancer microenvironment/spatial omics, biomarker development, immune/metabolic network analyses, and at least one causal-genetics study using Mendelian randomization (“causal link… Mendelian randomization”).
Methodological breadth (at title-level). Several items look like integrative “multi-omics / network” work (e.g., ceRNA network; immune-cell enrichment/expression map visualization) and some diagnostics/assay-type items (e.g., “fecal DNA… methylation testing”, “targeted proteomics… serum protein signature”).
Evidence of synthesis activity. Your list includes multiple reviews/systematic-review style titles (e.g., “systematic review”, “literature review”, “progress in research”). Even when reviews vary in quality, a review track often reflects familiarity with broader literatures.

4) Scientific rigor & reliability: what I can and can’t conclude

Can conclude (given your inputs): bibliometric magnitude (h-index and citations as provided) and topical breadth suggested by titles.

Cannot conclude (no abstracts/methods provided): sample sizes, study design (randomized vs observational), confounder handling, validation strategy, reproducibility practices, assay calibration details, statistical correction (multiple testing), or whether claims generalize beyond the studied cohorts.

Thus, a cautious confidence level is warranted. Citation volume supports visibility, but does not certify internal validity or translational correctness.

5) Evidence gaps & blind spots (how the review could be wrong)

Name disambiguation. The OpenAlex “Zeping Han” match may include works from more than one person with similar names; that can distort h-index/citation counts.
Publication bias. If the author’s portfolio is weighted toward positive biomarker associations, the apparent impact may reflect selective reporting.
HARKing risk in omics/biomarker narratives. Without methods, I can’t assess whether analyses were pre-registered or whether “novel networks” were discovered and then retrofitted to outcomes.
Reproducibility uncertainty. Titles alone can’t tell whether independent cohorts, technical replicates, or external validation were performed.
Generalization uncertainty. Many biomedical studies are cohort- and platform-dependent (assay batch effects, demographic differences, cancer subtype composition), which cannot be verified from titles.

6) Visual bibliography: what’s in your provided list

Table uses your supplied titles only; no DOIs/years were provided for these specific 17 items.

Paper title (as provided)	Category (title-level)	Paper ID (provided)
Exploring the causal link between serum 25-hydroxyvitamin D concentrations and idiopathic sudden sensorineural hearing loss: Insights gained from a Mendelian randomization study involving two independent samples	Genetics & causal inference	3767efb332d6c6e6dc6e8e5f3d39551205226584
Post-translational modifications of protein and lung cancer	Cancer biology / mechanisms	79229051906a8629b8bea9387f12274092ecc6af
Balamuthia mandrillaris - EBV Coinfective Encephalitis Diagnosed by MetaCAP: Comparative mNGS Validation and Epidemiological Landscape from 41 Chinese Cases.	Infectious disease / diagnostics	8b7d2f797eab7ba57dca9a6a9ddb5b5e67f59983
Enterocolic lymphocytic phlebitis: Clinical insights from a literature review.	Review / literature synthesis	c49945ccac89b79f9a1ad26cdd1f015bbd3c9bf6
Characteristics of the immune microenvironment, metabolic microenvironment, and gut microbiota in prostate cancer.	Cancer microenvironment	cd870144ee5e6dcac10dc83f4cbce15be5fb410b
Non-coding RNAs are involved in tumor cell death and affect tumorigenesis, progression, and treatment: a systematic review	Review / systematic review	1f49d256e3f8fd595970ce81101d1728b2f7692f
Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population	Biomarkers / diagnostics	6246d561b8dd6dddb3be88f7514e26847c2af14e
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming.	Cancer biology / mechanisms	b8ccdea4cc15ee4f0571fc9844218d58d50e1e1c
The role of protein post-translational modifications in prostate cancer	Cancer biology / mechanisms	c6c1bb7a07757d9dbcb01e77e8274fd2ace6c365
circICMT upregulates and suppresses the malignant behavior of bladder cancer	Biomarkers / ncRNA (title-level)	cb6e35a2823533956399bd50a240f935c8cfdac7
Identification and validation of a novel glycolysis-related ceRNA network for sepsis-induced cardiomyopathy	Immune/metabolic networks	dda032b8395c87705390fea0c3f743cb8f81e330
CIEC: Cross-tissue Immune Cell Type Enrichment and Expression Map Visualization for Cancer	Tools / computational visualization	f0854bfcb621205a0dacea3739cf8d7f741cf345
Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity.	Biomarkers / diagnostics	f11c5671dfafc4c745907f000f06a6c9fbee91ad
A Targeted Proteomics Approach Reveals a Serum Protein Signature as a Diagnostic Biomarker for Colorectal Cancer	Biomarkers / diagnostics	fd7de7369bd38e0dfc730b244d6b236b6fb36e13
circMSH3 is a potential biomarker for the diagnosis of colorectal cancer and affects the distant metastasis of colorectal cancer	Biomarkers / ncRNA (title-level)	147346f04a35ddf8da51c9c6cd48de1c21c57be6
Progress in research on tumor microenvironment-based spatial omics technologies	Review / conceptual survey	7f0a5ec57dd2f1e9e63da0fefd924f38468cc635
Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation	Mechanistic networks (title-level)	b619707bbe89cac4436eca073ca0b249cd931fb1

7) What would most improve a true scientific quality assessment?

Abstract + methods for each key paper to verify design strength (prospective/retrospective, blinding, controls, batch handling, preregistration).
Validation details: independent cohorts, external datasets, negative controls, and calibration/ROC methodology (where relevant).
For causal inference: MR assumptions and sensitivity analyses (e.g., pleiotropy robustness) — titles alone cannot establish this.
For omics/network studies: multiple-testing correction, leakage checks, and whether “validation” is truly out-of-sample.
For computational tools (e.g., “visualization for cancer”): availability of code/data and benchmarking against baselines.

Bottom line (confidence-weighted)

The bibliometric signal you provided suggests the author’s work has attracted attention (h-index and citation counts as provided). However, the scientific strength (rigor, validation, reproducibility) cannot be verified from titles and high-level metrics alone; the most defensible conclusion is “moderate evidence of broad applied expertise, high uncertainty about methodological quality.”

Run-time upgrade suggestion: If you want an actually rigorous assessment, upload PDFs/DOIs for the 17 listed papers, and I can extract methods, sample sizes, statistics, and validation schemes.

Feedback:

Updated: April 13, 2026